Table 1 Baseline clinical characteristics of patients with postoperative locoregional recurrence of oesophageal squamous cell carcinoma
Variable | n (%) |
|---|---|
Gender | Â |
 Male | 20 (74.1) |
 Female | 7 (25.9) |
Age (year) | Â |
 Median (range) | 55 (42–75) |
 <60 | 20 (74.1) |
 ≥60 | 7 (25.9) |
ECOG PS | Â |
 0–1 | 17 (63.0) |
 2 | 10 (37.0) |
BMI (kg/m2) | Â |
 <18.5 | 8 (29.6) |
 ≥18.5 | 19 (70.4) |
CCI | Â |
 0 | 17 (63.0) |
 1–2 | 10 (37.0) |
Smoking status | Â |
 Former or current smoker | 15 (55.6) |
 Non-smoker | 12 (44.4) |
Drinking | Â |
 No | 15 (55.6) |
 Yes | 12 (44.4) |
Primary tumor location | Â |
 Upper | 3 (11.1) |
 Middle | 21 (77.8) |
 Lower | 3 (11.1) |
TNM Stage of primary tumor a | Â |
 Ia, Ib | 2 (7.4) |
 IIa, IIb | 10 (37.0) |
 IIIa, IIIb | 15 (55.6) |
Histology of primary tumor | Â |
 Grade 1–2 | 23 (85.2) |
 Grade 3–4 | 4 (14.8) |
Primary radical surgery | Â |
 Two-incision oesophagectomy | 10 (37.0) |
 Three-incision oesophagectomy | 17 (63.0) |
Adjuvant chemotherapy after surgery | Â |
 No | 14 (48.1) |
 Yes | 13 (51.9) |
Time to recurrence after initial treatment | Â |
 Median (range, month) | 17 (4–132) |
 ≥1 year | 18 (66.7) |
 <1 year | 9 (33.3) |
Recurrence site | Â |
 Anastomosis with/without lymphadenopathy | 9 (33.3) |
 Supraclavicular and/or regional lymph node | 18 (66.7) |
